CoE IoT

The prompt has already been sent. Now the question is what do you?

We started this with a single prompt. A routine request. A senior manager who wasn’t reckless but fast. And within seconds, everything changed. Quietly, invisibly, irreversibly. You now know more than most executives in your industry. You know about the training pipelines quietly consuming your team’s prompts. You know about the shadow AI tools operating beneath your governance radar.

Why Grants Matter?

We all see the emerging technology growing rapidly and sectors like AI, advanced manufacturing, health-tech, climate-tech, and semiconductors, early-stage risk is naturally high. All these fields demand heavy upfront R&D, long validation cycles, regulatory approvals, and often hardware prototyping long before any real revenue visibility appears. It’s no surprise that private capital tends to be cautious at this stage.

So, What’s the Fix?

The answer is Computational drug discovery also called in silico drug discovery. This means instead of relying solely on wet-lab experiments, scientists use computers to simulate, screen, and predict how drug compounds will behave, cutting down the trial-and-error process.

The Evolution of AI & Industry 4.0 – What’s Next?

Dhaval Kanojiya Uncategorized 0 26Mar We have come a long way in advancement of the Manufacturing industry. From manual labour to machines that run themselves, Industry 4.0 is the latest leap forward. It is where digital technologies like Artificial Intelligence are making factories smarter and more efficient.